Trial intelligence / Profile preview

DaTSCAN SPECT Normal Database Study

2005-000895-41Phase 4Terminated

Sponsor
Hospital Clínic de Barcelona
Start
Jul 2005
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ioflupane I-123, sponsored by Hospital Clínic de Barcelona. Started Jul 2005; status: terminated.

02

Drugs

ioflupane I-123

Beyond the preview

Go deeper on 2005-000895-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000895-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call